Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 176	$ 33	$ 863	$ 33
Operating expenses:
Research and development	17,832	9,281	46,020	25,653
General and administrative	4,894	2,792	10,948	6,622
Total operating expenses	22,726	12,073	56,968	32,275
Loss from operations	(22,550)	(12,040)	(56,105)	(32,242)
Other income, net:
Interest income	1,900	1,096	4,709	1,531
Other expense, net	(9)	(1)	(72)	(3)
Total other income, net	1,891	1,095	4,637	1,528
Loss before benefit for income taxes	(20,659)	(10,945)	(51,468)	(30,714)
Benefit for income taxes	136		338
Net loss attributable to common stockholders	$ (20,523)	$ (10,945)	$ (51,130)	$ (30,714)
Net loss per share attributable to common stockholders - Basic	$ (8.4)	$ (5.45)	$ (21.87)	$ (16.49)
Net loss per share attributable to common stockholders - Diluted	$ (8.4)	$ (5.45)	$ (21.87)	$ (16.49)
Weighted-average shares outstanding - Basic	2,443,678	2,007,620	2,337,891	1,862,036
Weighted-average shares outstanding - Diluted	2,443,678	2,007,620	2,337,891	1,862,036
Comprehensive loss:
Net Income (Loss)	$ (20,523)	$ (10,945)	$ (51,130)	$ (30,714)
Net unrealized gain on available-for-sale marketable securities	184		176
Total other comprehensive income	184		176
Comprehensive loss	$ (20,339)	$ (10,945)	$ (50,954)	$ (30,714)